HomeACADEMIA
ACADEMIA

New Atherosclerosis Guidelines Likely to Add PCSK9 Inhibitors for Primary Prevention of CAD in Familial Hypercholesterolemia
(Jul.20.2016)

Shizuya Yamashita, chairman of JAS's guidelines drafting committee
The new guidelines being drafted by the Japan Atherosclerosis Society, due out in 2017, are expected to recommend the use of PCSK9 inhibitors for the primary prevention of coronary artery disease (CAD) in familial hypercholesterolemia (FH), Shizuya Yamashita, head of the society’s guidelines drafting committee, told Jiho ...
(LOG IN FOR FULL STORY)

News Calendar